{\rtf1\ansi\deff0\deftab360

{\fonttbl
{\f0\fswiss\fcharset0 Arial}
{\f1\froman\fcharset0 Times New Roman}
{\f2\fswiss\fcharset0 Verdana}
{\f3\froman\fcharset2 Symbol}
}

{\colortbl;
\red0\green0\blue0;
}

{\info
{\author Biblio 7.x}{\operator }{\title Biblio RTF Export}}

\f1\fs24
\paperw11907\paperh16839
\pgncont\pgndec\pgnstarts1\pgnrestart
Benelli E, Naviglio S, De Leo L, Stera G, Giangreco M, Ronfani L, Villanacci V, Martelossi S, Ventura A, Not T. Changing Epidemiology of Liver Involvement in Children With Celiac Disease. J Pediatr Gastroenterol Nutr 2019;68(4):547-551.\par \par De Leo L, Aeschlimann D, Hadjivassiliou M, Aeschlimann P, Salce N, Vatta S, Ziberna F, Cozzi G, Martelossi S, Ventura A, Not T. Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure. J Pediatr Gastroenterol Nutr 2018;66(1):64-68.\par \par De Leo L, Villanacci V, Ziberna F, Vatta S, Martelossi S, Di Leo G, Zanchi C, Bramuzzo M, Giudici F, Ventura A, Not T. Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children. Gastrointest Endosc 2018;88(3):521-526.\par \par Fornasaro S, Vicario A, De Leo L, Bonifacio A, Not T, Sergo V. Potential use of MCR-ALS for the identification of coeliac-related biochemical changes in hyperspectral Raman maps from pediatric intestinal biopsies. Integr Biol (Camb) 2018;10(6):356-363.\par \par Zanella S, De Leo L, Nguyen-Ngoc-Quynh L, Nguyen-Duy B, Not T, Tran-Thi-Chi M, Phung-Duc S, Le-Thanh H, Malaventura C, Vatta S, Ziberna F, Mazzocco M, Volpato S, Phung-Tuyet L, Le-Thi-Minh H, Borgna-Pignatti C. Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children. BMJ Open 2016;6(6):e011173.\par \par Di Sabatino A, Giuffrida P, Fornasa G, Salvatore C, Vanoli A, Naviglio S, De Leo L, Pasini A, De Amici M, Alvisi C, Not T, Rescigno M, Corazza GRoberto. Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease. Dig Liver Dis 2016;48(7):745-52.\par \par Ziberna F, De Lorenzo G, Schiavon V, Arnoldi F, Quaglia S, De Leo L, Vatta S, Martelossi S, Burrone OR, Ventura A, Not T. Lack of Evidence of Rotavirus-Dependent Molecular Mimicry as a Trigger of Celiac Disease. Clin Exp Immunol 2016;\par \par Habtamu HB, Sentic M, Silvestrini M, De Leo L, Not T, Arbault S, Manojlovic D, Sojic N, Ugo P. A Sensitive Electrochemiluminescence Immunosensor for Celiac Disease Diagnosis Based on Nanoelectrode Ensembles. Anal Chem 2015;87(24):12080-7.\par \par De Leo L, Quaglia S, Ziberna F, Vatta S, Martelossi S, Maschio M, Not T. Serum anti-tissue transglutaminase antibodies detected during febrile illness may not be produced by the intestinal mucosa. J Pediatr 2015;166(3):761-3.\par \par Quaglia S, De Leo L, Ziberna F, Vatta S, Villanacci V, Granzotto M, Petix V, Martelossi S, Di Leo G, Torelli L, Not T. Intestinal-mucosa anti-transglutaminase antibody assays to test for genetic gluten intolerance. Cell Mol Immunol 2014;11(6):617-20.\par \par Korponay-Szab\'f3 IRita, Simon-Vecsei Z, De Leo L, Not T. Gluten-dependent intestinal autoimmune response. Curr Pharm Des 2012;18(35):5753-8.\par \par Goldblum SE, Rai U, Tripathi A, Thakar M, De Leo L, Di Toro N, Not T, Ramachandran R, Puche AC, Hollenberg MD, Fasano A. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. FASEB J 2011;25(1):144-58.\par \par Marcuzzi A, De Leo L, Decorti G, Crovella S, Tommasini A, Pontillo A. The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency. Pediatr Res 2011;70(1):78-82.\par \par De Leo L, Di Toro N, Decorti G, Malus\'e0 N, Ventura A, Not T. Fasting increases tobramycin oral absorption in mice. Antimicrob Agents Chemother 2010;54(4):1644-6.\par \par De Leo L, Marcuzzi A, Decorti G, Tommasini A, Crovella S, Pontillo A. Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: in vitro and in vivo approaches. Pharmacol Res 2010;61(6):506-10.\par \par }